| Code | Désignation | Taux de droit |
|---|---|---|
| — | ||
| 6.5% | ||
| 6.5% | ||
| 6.5% | ||
| 6.5% | ||
| 6.5% | ||
| 0% | ||
| — | ||
| 6.5% | ||
| — | ||
| 6.5% | ||
| 6.5% |
| 2934208035 | 3-Methyl-1,2-benzothiazole-1,1-dioxide (CAS RN 34989-82-7) with a purity by weight of 95 % or more | 6.5% |
| 2934208070 | N,N-Bis(1,3-benzothiazol-2-ylsulphanyl)-2-methylpropan-2-amine (CAS RN 3741-80-8) | 6.5% |
| 2934208090 | Other | 0% |
| 2934300000 | Compounds containing in the structure a phenothiazine ring-system (whether or not hydrogenated), not further fused | — |
| 2934301000 | Thiethylperazine (INN); thioridazine (INN) and its salts | 0% |
| 2934309000 | Other | — |
| 2934309010 | 2-Methylthiophenothiazine (CAS RN 7643-08-5) | 6.5% |
| 2934309090 | Other | 0% |
| 2934910000 | Other | 0% |
| 2934920000 | Other fentanyls and their derivatives | 0% |
| 2934990000 | Other | — |
| 2934999000 | Other | — |
| 2934999004 | Silthiofam (ISO) (CAS RN 175217-20-6) with a purity by weight of 98 % or more | 6.5% |
| 2934999005 | (S)-2-Methyl-1-(6-nitropyridin-3-yl)-4-(oxetan-3-yl)piperazine (CAS RN 1895867-67-0) with a purity by weight of 97 % or more | 6.5% |
| 2934999006 | Cis-[2-(2,4-Dichlorodiphenyl)-2-(1H-imidazol-1-ylmethyl)-1,3-dioxolan-4yl]methyl-4-methylbenzenesulfonate (CAS RN 134071-44-6) with a purity by weight of 99 % or more | 6.5% |
| 2934999007 | Cedazuridine (INN) (CAS RN 1141397-80-9) with a purity by weight of 99 % or more | 6.5% |
| 2934999008 | (R)-tert-butyl 2-(6-(5-chloro-2-((tetrahydro-2H-pyran-4-yl)amino)pyrimidin-4-yl)-1-oxoisoindolin-2-yl)propanoate (CAS RN 2095665-45-3) with a purity by weight of 98 % or more | 6.5% |
| 2934999010 | Fluralaner (INN) (CAS RN 864731-61-3) | 6.5% |
| 2934999012 | Dimethomorph (ISO) (CAS RN 110488-70-5) | 6.5% |
| 2934999013 | (6S)-6-methyl-5,6-Dihydro-4H-thieno[2,3-b]thiopyran4-one-7,7-dioxide (CAS RN 148719-91-9) with a purity by weight of 98 % or more | 6.5% |
| 2934999014 | 2-Mercaptoadenosine (CAS RN 43157-50-2) with a purity by weight of 98 % or more | 6.5% |
| 2934999016 | Difenoconazole (ISO) (CAS RN 119446-68-3) | 6.5% |
| 2934999017 | (S)-4-(tert-butoxycarbonyl)-1,4-oxazepane-2-carboxylic acid (CAS RN 1273567-44-4) with a purity by weight of 95 % or more | 6.5% |
| 2934999018 | Methyl (1R,3R)-1-(1,3-benzodioxol-5-yl)-2-(2-chloroacetyl)-1,3,4,9-tetrahydropyrido[5,4-b]indole-3-carboxylate (CAS RN 171489-59-1) with a purity by weight of 99 % or more | 6.5% |
| 2934999019 | (4R,6S)-6-Methyl-7,7-dioxo-5,6-dihydro-4H-thieno[2,3-b]thiopyran-4-ol (CAS RN 147128-77-6) with a purity by weight of 94 % or more | 6.5% |
| 2934999020 | Thiophene (CAS RN 110-02-1) | 6.5% |
| 2934999021 | Acesulfame potassium (potassium salt of 6-methyl-1,2,3-oxathiazin-4(3H)-one 2,2-dioxide; CAS RN 55589-62-3) ace-K | 0% |
| 2934999022 | 4-(Oxiran-2-ylmethoxy)-9H-carbazole (CAS RN 51997-51-4) with a purity by weight of 97 % or more | 6.5% |
| 2934999024 | Flufenacet (ISO) (CAS RN 142459-58-3) with a purity by weight of 95 % or more | 6.5% |
| 2934999025 | 2,4-Diethyl-9H-thioxanthen-9-one (CAS RN 82799-44-8) | 6.5% |
| 2934999026 | 4-Methylmorpholine 4-oxide in an aqueous solution (CAS RN 7529-22-8) | 6.5% |
| 2934999027 | 2-(4-Hydroxyphenyl)-1-benzothiophene-6-ol (CAS RN 63676-22-2) | 6.5% |
| 2934999028 | 11-(Piperazin-1-yl)dibenzo[b,f][1,4]thiazepine dihydrochloride|(CAS RN 111974-74-4) | 6.5% |
| 2934999030 | Dibenzo[b,f][1,4]thiazepin-11(10H)-one (CAS RN 3159-07-7) | 6.5% |
| 2934999031 | Thenoic acid (CAS RN 1918-77-0) with a purity by weight of 97 % or more | 6.5% |
| 2934999035 | Nusinersen sodium (INNM) (CAS RN 1258984-36-9) with a purity by weight of 95 % or more | 6.5% |
| 2934999037 | 4-Propan-2-ylmorpholine (CAS RN 1004-14-4) | 6.5% |
| 2934999038 | 2-Chloro-9H-thioxanthen-9-one (CAS RN 86-39-5) with a purity by weight of 98 % or more | 6.5% |
| 2934999039 | 4-(Oxiran-2-ylmethoxy)-9H-carbazole (CAS RN 51997-51-4) | 6.5% |
| 2934999040 | 2,3-Pyrazinedicarboxylic anhydride (CAS RN 4744-50-7) with a purity by weight of 95 % or more | 6.5% |
| 2934999041 | 11-[4-(2-Chloro-ethyl)-1-piperazinyl]dibenzo(b,f)(1,4)thiazepine (CAS RN 352232-17-8) | 6.5% |
| 2934999045 | 4-[4-[(5s)-5-(Aminomethyl)-2-oxo-3-oxazolidinyl] phenyl]-3-morpholinone, hydrochloride (CAS RN 898543-06-1) with a purity by weight of 98 % or more | 6.5% |
| 2934999048 | Propan-2-ol|--|2-methyl-4-(4-methylpiperazin-1-yl)-10H-thieno[2,3-b][1,5]benzodiazepine (1:2) dihydrate, (CAS RN 864743-41-9) | 6.5% |
| 2934999049 | Cytidine 5'-(disodium phosphate) (CAS RN 6757-06-8) | 6.5% |
| 2934999050 | Vutrisiran (INN) (CAS RN 1867157-35-4) with a purity by weight of 98 % or more | 6.5% |
| 2934999051 | Uridine 5'-triphosphate trisodium salt (CAS RN 19817-92-6) with a dry weight purity of 90 % or more | 6.5% |
| 2934999055 | Uridine (CAS RN 58-96-8) with a purity by weight of 98 % or more | 6.5% |
| 2934999056 | 1-[5-(2,6-Difluorophenyl)-4,5-dihydro-1,2-oxazol-3-yl]ethanone (CAS RN 1173693-36-1) | 6.5% |
| 2934999057 | Dimethenamide-P (ISO) (CAS RN 163515-14-8) with a purity by weight of 93 % or more | — |
| 2934999059 | Dolutegravir (INN) (CAS|RN|1051375-16-6) or dolutegravir sodium (CAS|RN|1051375-19-9) | 6.5% |
| 2934999060 | DL-Homocysteine thiolactone hydrochloride|(CAS RN 6038-19-3) | 6.5% |
| 2934999061 | 5-(1,2-dithiolan-3-yl)valeric acid (CAS RN 1077-28-7) | 6.5% |
| 2934999063 | (2b,3a,5a,16b,17b)-2-(morpholin-4-yl)-16-(pyrrolidin-1-yl)androstane-3,17-diol (CAS|RN|119302-20-4) | 6.5% |
| 2934999064 | 2-Bromo-5-benzoylthiophene (CAS RN 31161-46-3) | 6.5% |
| 2934999065 | Benzo[b]thiophen-10-methoxycycloheptanone (CAS RN 59743-84-9) with a purity by weight of 98 % or more | 6.5% |
| 2934999066 | Tetrahydrothiophene-1,1-dioxide (CAS RN 126-33-0) | 6.5% |
| 2934999067 | 5-Chlorothiophene-2-carboxylic acid (CAS RN 24065-33-6) | 6.5% |
| 2934999069 | 3-methyl-5-(4,4,5,5-tetramethyl-1,3,2-dioxaborolan-2-yl)benzo[d]oxazol-2(3H)-one (CAS RN 1220696-32-1) with a purity by weight of 95 % or more | 6.5% |
| 2934999070 | 1,3,4-thiadiazolidine-2,5-dithione (CAS RN 1072-71-5) with a purity by weight of 95 % or more | 6.5% |
| 2934999071 | 3,4-Dichloro-1,2,5-thiadiazole (CAS RN 5728-20-1) with a purity by weight of 99 % or more | 6.5% |
| 2934999072 | 2-Trifluoromethyl-9-allyl-9-thioxanthen-ol (CAS RN 850808-70-7) with a purity by weight of 98 % or more | 6.5% |
| 2934999074 | 2-Isopropylthioxanthone (CAS RN 5495-84-1) | 6.5% |
| 2934999075 | (4R-cis)-1,1-Dimethylethyl-6-[2[2-(4-fluorophenyl)-5-(1-isopropyl)-3-phenyl-4-[(phenylamino)carbonyl]-1H-pyrrol-1-yl]ethyl]-2,2-dimethyl-1,3-dioxane-4-acetate (CAS RN 125971-95-1) | 6.5% |
| 2934999076 | Nedosiran sodium (INNM) (CAS RN 2247026-22-6) with a purity by weight of 95 % or more | — |
| 2934999077 | Tazemetostat (INN) (CAS 1403254-99-8) with a purity by weight of 99 % or more and its salts | 6.5% |
| 2934999078 | Disodium uridine-5'-monophosphate (CAS RN 3387-36-8) with a purity by weight of 98 % or more | — |
| 2934999081 | 1-(4-aminophenyl)-5-(morpholin-4-yl)-2,3-dihydropyridin-6-one (CAS RN 1267610-26-3) with a purity by weight of 98 % or more | 6.5% |
| 2934999082 | Rel-(3aR,12bR)-11-Chloro-2,3,3a,12b-tetrahydro-2-methyl-1H-dibenz[2,3:6,7]oxepino[4,5-c]pyrrol-1-one (CAS RN 129385-59-7) with a purity by weight of 97 % or more | 6.5% |
| 2934999083 | Flumioxazin (ISO) (CAS RN 103361-09-7) of a purity by weight of 96 % or more | 6.5% |
| 2934999085 | Gilteritinib (INN) (CAS 1254053-43-4) with a purity by weight of 98 % or more and its salts | 6.5% |
| 2934999086 | Dithianon (ISO) (CAS RN 3347-22-6) | 6.5% |
| 2934999087 | 2,2'-(1,4-Phenylene)bis(4H-3,1-benzoxazin-4-one) (CAS RN 18600-59-4) | 6.5% |
| 2934999088 | (7S,9aS)-7-((benzyloxy)methyl)octahydropyrazino[2,1-c][1,4]oxazine dioxalate (CAS RN 1268364-46-0) | 6.5% |
| 2934999089 | 6R-[6α,7β(Z)]]-7-[2-Furyl(methoxyimino)acetamido]-3-(hydroxymethyl)-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (CAS RN 56271-94-4) with a purity by weight of 96 % or more | — |
| 2934999090 | Other | 0% |
Trouver le code tarifaire exact
Trouver le code tarifaire exact